BPC-157 vs TB-500: Structure, Stability and How Each Is Verified

BPC-157 is a pentadecapeptide, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular formula of C62H98N16O22 and an average molecular weight of 1419.53 Da. The sequence corresponds to a segment of a protein identified in human gastric juice, which is where its stability at low pH comes from. It has free N- and C-termini and no post-synthetic modification.

TB-500 is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, residues 17 to 23 of thymosin beta-4, the 43-residue parent protein. Its formula is C37H67N9O12 and its average molecular weight is 861.99 Da. The N-terminal acetyl group is part of the definition of the compound, not a protecting group left behind by synthesis. This fragment carries the actin-binding motif studied in cell migration models, and it is the fragment, not the full protein, that almost all published work uses.

The two are studied in overlapping model systems, connective tissue and endothelial work in particular, which is the reason they are so often ordered together. Mechanistically they are unrelated: the BPC-157 literature centers on VEGFR2 and nitric oxide pathway signaling, the TB-500 literature on sequestration of monomeric actin.

BPC-157 contains three consecutive prolines, two adjacent aspartates and a glutamate, and no methionine, cysteine, tryptophan or asparagine. That composition is unusually forgiving. There is no residue that oxidizes readily, no asparagine to deamidate, and the proline run resists protease attack. The Asp-Asp pair is the one site to watch, since aspartate followed by a small residue can form an aspartimide over long storage, but the following residue here is alanine rather than glycine and the rate is slow.

TB-500 has two lysines, two threonines, a glutamate and a C-terminal glutamine. Glutamine deamidates far more slowly than asparagine, so the compound is stable in solution, but a deamidated variant (0.98 Da heavier) is the impurity a careful analyst looks for in an aged lot. The two lysines make the peptide cationic at neutral pH, which affects both its retention on reversed phase and its tendency to adsorb to untreated plastic.

In practice both are among the easiest peptides in the catalog to work with. Both dissolve immediately in water, both tolerate ordinary handling, and neither needs the light protection that tryptophan-containing sequences do.

A synthetic peptide is purified in trifluoroacetic acid and arrives as a trifluoroacetate salt unless the manufacturer exchanges the counter-ion. For BPC-157, two forms are in wide circulation: the acetate salt and an arginine salt. They contain the same peptide, but they behave differently on reversed-phase HPLC, have different net peptide contents per milligram of cake, and dissolve to solutions of different pH.

That is why a purity figure without a salt form is an incomplete answer. Two certificates can both say 99.4 % and be describing cakes whose peptide content per milligram differs by several percent. The Certus certificate for every BPC-157 lot states the salt form alongside the purity, the net peptide content by amino acid analysis and the residual trifluoroacetate by ion chromatography.

TB-500 is generally supplied as the acetate or trifluoroacetate salt. With two lysines and a free N-terminus, it carries up to three counter-ions per molecule, and on an 862 Da peptide those counter-ions are a meaningful share of the cake mass. Net peptide content matters more for a small peptide than a large one for exactly this reason.

BPC-157 is the stability benchmark of the catalog. Our data support a reconstituted stock held at 2-8 °C for thirty days with under 2 % loss by HPLC, and the compound tolerates low pH without rapid hydrolysis, which is consistent with its origin. Lyophilized at -20 °C it is stable through the labeled expiry.

TB-500 is also stable reconstituted at 2-8 °C. The slow pathway is deamidation at the C-terminal glutamine; the fast pathway, if you are careless, is adsorptive loss of a small cationic peptide to ordinary polypropylene. Low-binding tubes remove that variable. Both compounds should be aliquoted before freezing rather than frozen and thawed repeatedly, which is the general rule for every peptide and is covered in the reconstitution and storage guide.

For BPC-157: purity by reversed-phase HPLC at 214 nm against a release specification of 99.0 %, an LC-MS observed mass within 1.0 Da of 1419.53, the salt form, net peptide content, water content by Karl Fischer, residual trifluoroacetate, endotoxin in EU/mg and sterility. A certificate that omits the salt form or the net content is answering the easy question only.

For TB-500 the identity line does more work than usual. The acetyl group adds 42.01 Da to the mass, so un-acetylated material, which is cheaper to make and is a common substitution in this compound, reads 819.98 Da rather than 861.99 Da on LC-MS. That difference is unmistakable if the analyst looks for it and invisible if the certificate reports only 'conforms'. The Certus certificate confirms the acetyl group by observed mass on every lot.

Both compounds are released on HPLC and LC-MS as orthogonal methods, plus endotoxin and sterility, because a peptide destined for cell culture has to pass both, and neither test can stand in for the other.

The BPC-157 + TB-500 blend is the two compounds co-lyophilized at a 1:1 mass ratio in a single vial. It exists because the pairing is the most common combination in the connective tissue literature, on the reasoning that the two act through separable mechanisms, so a combined preparation lets one experimental arm cover both without a second reconstitution.

Blends are where certificate quality is most often abandoned, because a single purity number for a mixture means nothing. The Certus approach is three assays rather than one: each component is assayed independently before blending, the finished vial is assayed again on a gradient that resolves both peaks, and the certificate reports a purity and a measured mass ratio per component. With the ratio in hand you can calculate each component's concentration in the reconstituted solution exactly, which a single number cannot give you.

If your design needs the two compounds in separate arms, or at a ratio other than 1:1, the single vials are the right purchase. The blend is a convenience for the case where both are always present together, and it is certified so that convenience does not cost you information.